金黄地鼠PrP基因组织特异性表达的研究

金黄地鼠是研究动物传染性海绵状脑病的理想模型动物之一,我们利用实时荧光定量RT-PCR技术,构建标准重组质粒制备标准曲线,对中枢神经系统的4个不同部位及外周6个组织提取总RNA,反转录后进行PrP基因表达的定量.结果发现,脑的四个检测部位都呈现高的表达量;在外周器官中,淋巴结的表达量和全脑相当,脾脏、心脏、肝脏和肺脏呈现中等程度的表达,肾脏的表达量最低.本研究的结果对于探讨朊蛋白的基本功能和不同组织在传染性海绵状病理发生中的作用,提供了基础数据.     

黄鳝IRF-4和IRF-10的表达研究

目的:干扰素调节因子是一类能够调控干扰素及其相关免疫基因表达的转录因子,研究黄鳝干扰素调节因子的结构及表达有助于阐明黄鳝抗病毒的机理。方法:利用PCR扩增技术获得了黄鳝干扰素调节因子10(IRF-10)和IRF-4的部分cDNA序列,再利用半定量PCR技术检测了黄鳝不同发育阶段、不同组织IRF-10和IRF-4的表达。结果:IRF-10和IRF-4在黄鳝三个不同的发育阶段表达量基本一致,但两者在黄鳝不同组织表达呈现明显的差异,IRF-10组成型表达于黄鳝各个组织中,而IRF-4仅在肠、中肾和脑中呈现很高的表达,其他组织表达很弱。结论:IRF-10组成型地表达于黄鳝各个组织,且表达量很高;而IRF-4中仅在主要免疫器官表达,且表达量较弱。     

鸡miR-9不同组织表达差异及其功能预测分析

miRNA在动物生长发育过程中有重要作用. 本文采用定制茎环反转录引物,利用实时荧光定量PCR技术构建miR-9在鸡2个阶段11个组织中的表达谱,同时用TargetScan5.1与PicTar两种计算方法对其进行靶基因预测,交集的基因集合分别进行GO（gene ontology）富集分析和生物通路富集分析. 结果表明,采用实时定量PCR检测的miR-9在鸡下丘脑中的表达量和高通量测序结果一致;采用实时定量PCR在对不同组织定量结果表明,miR-9在0日龄鸡的肾脏、下丘脑、腿肌和大脑中高丰度表达,在成年鸡表达量较高为大脑、腿肌、心脏、小脑和下丘脑.在同一组织的0日龄和成年鸡中表达呈现时序性,除肝脏的表达量差异不显著,其他10个组织miR-9表达量差异显著（P<0.05）.预测到交集靶基因有160个.涉及到多个KEGG通路和GO富集中.GO分类结果显示,这些基因分布于63个群中,其中基因超过45个基因群集有26个群,与代谢有关的群有11个. 其它与发育、调控等过程有关. 在KEGG通路分析中,显著的通路有细胞骨架调控、细胞增殖和分化有关的通路（P<0.01）等5个通路. 表明miR 9基因的表达有组织和时序特异性,靶基因参与细胞代谢、生长发育和调控.这些结果为进一步验证miR 9基因在在脑中调控生长发育过程中的作用奠定了基础.     

低温对鲤鱼的5个基因在不同组织中表达量的影响

本研究应用实时荧光定量 PCR技术对抑制性消减杂交所得到的鲤鱼不同温度下差异表达的5个基因做进一步的研究.结果表明: 水温由16℃降至4℃(骤降点)的过程中,在鲤鱼的肝、肠组织中,LKE-25基因的表达量呈下降趋势,而LKE-62基因则呈上升趋势;在肾脏组织中,LKE-48-1、 LKE-48-2和LKE-59基因的表达量呈上升趋势,且随着4℃维持时间的延长,其表达量逐渐下降.LKE-25和LKE-59基因在4℃同一尾鱼的心脏、脑、肝、脾、肾、肠组织中的表达量上有很大差异,其中LKE-25基因在心、LKE-59基因在肾组织中的表达量最高 .本实验所研究的5个基因在不同温度、不同组织表达量的显著差异,证明了这些基因与水温相关且有组织特异性 [动物学报 54(3):460-466,2008].     

低氧环境对高原鼢鼠不同组织VEGF165b基因表达量及微血管密度的影响

目的：探讨高原低氧环境下高原鼢鼠不同组织血管内皮生长因子165b （VEGF_165b）表达量及微血管密度（MVD）的变化。方法：克隆高原鼢鼠VEGF_165b基因并测定其在不同海拔脑、肺和骨骼肌组织内的表达量;免疫组化法观察脑、肺和骨骼肌组织内微血管并测定其在不同海拔组织内的密度。结果：高海拔VEGF_165b表达量显著低于低海拔表达量（P<0.05）;微血管密度随海拔高度升高而增加（P<0.05）。结论：VEGF_165b基因调节动物组织微血管密度是高原动物适应低氧环境的重要机制之一。     

神经生长因子在不同周龄小鼠睾丸组织中的表达

目的研究神经生长因子在小鼠不同周龄睾丸组织中的定量和定位表达。方法分别剖取不同周龄雄性小鼠的睾丸组织,部分提取总RNA,real-time PCR相对定量分析神经生长因子mRNA的表达量;另外部分组织固定、包埋,进行SABC法免疫组化分析,以观察神经生长因子蛋白在各周睾丸组织中的定位。结果Real-timePCR定量分析表明:小鼠生后1周龄睾丸组织有神经生长因子mRNA的表达,生后3周龄表达量达峰值,5周之后随鼠龄的增加呈下降趋势,成年小鼠睾丸组织的神经生长因子mRNA表达维持在一定水平。免疫组化定位分析显示:睾丸组织的神经生长因子蛋白表达于小鼠出生后的各个时期内,1周龄睾丸组织免疫阳性反应主要位于支持细胞,精原细胞也有着色;3周龄睾丸组织的间质细胞、各级生精细胞、支持细胞、管周肌样细胞表达均呈现阳性;5周后的睾丸组织内神经生长因子呈低水平表达,主要表达于间质细胞和生精细胞内。结论神经生长因子mRNA的表达量随着小鼠睾丸的生长发育期存在着一定的规律性变化;神经生长因子蛋白的表达在小鼠睾丸生长发育的不同时期其主要表达部位不同。     

团头鲂生长相关基因在不同发育时期生长轴组织的表达分析

为了探讨生长相关基因对团头鲂生长发育的调控, 研究采用Real-time PCR的方法定量分析了团头鲂6个生长相关基因在其不同生长发育阶段(3、6、12月龄)相关组织(脑、肝脏、肌肉)的表达情况, 并比较了这些基因在生长快和慢两个群体的表达差异. 结果显示: GHRs基因在肝脏与肌肉中的表达量高于脑, 在6月龄表达量高于3月龄与12月龄, 生长快群体中的表达量高于生长慢群体(P0.05); IGFs基因在三个组织中均有表达, 肝脏表达量最高, 生长快群体中的表达量高于生长慢群体(P0.05). MSTN a与MSTN b基因在组织中表达模式存在差异, MSTN a在肌肉中高表达, MSTN b主要在脑与肝脏中表达. HCL聚类结果表明: 除了MSTN a基因外, 其他5个基因在生长差异的两个群体中表达量均分别聚为一支. 不同时期组织表达聚类结果表明, 除了3月龄肝脏与12月龄肌肉组织, 6个生长相关基因在不同时期的同一组织中的表达模式存在相似性. Pearson相关分析显示: GHRs与IGFs呈正相关, MSTN a基因与GHR 2、IGFs基因呈负相关, 相同基因在两个群体中呈极显著相关(P0.01).       

干旱胁迫对苗期大豆异黄酮合成的影响

以不同耐旱性的2个大豆品种(高耐旱JP-6、低耐旱JP-16)为研究材料,采用高效液相色谱和实时荧光定量PCR技术,分析不同时间持续干旱胁迫下,大豆叶片和根系中异黄酮的积累变化及关键酶基因的表达情况.结果表明:大豆根部异黄酮含量显著高于叶部,而异黄酮关键酶基因的表达量则在叶片中更高,耐旱品种JP-6根部的异黄酮积累量更大.随着干旱胁迫持续时间的增加,不同耐旱品种的异黄酮合成与积累变化规律存在显著差异:强耐旱品种JP-6的根和叶中,异黄酮积累量均呈现先下降后升高的趋势;而弱耐旱品种JP-16则相反,异黄酮积累量在不同部位中均呈现先上升后降低的趋势;除JP-6叶中C4H、4CL、IFS2等异黄酮合成上游基因外,其他不同品种、不同部位的关键酶基因表达量均随着干旱胁迫持续时间的增加,呈现先下降后上升的趋势.大豆叶片是异黄酮的主要合成部位,大豆根部也存在少量的异黄酮合成.弱耐旱大豆根部的异黄酮合成和最终积累量均较低,强耐旱品种则较高.根部异黄酮积累量高的大豆品种,其耐旱性更强.     

拟南芥6个酪蛋白激酶基因的组织表达及其生物信息学分析

利用实时荧光定量PCR技术研究6个酪蛋白激酶基因在不同组织中的表达特性.结果表明:6个基因在各个器官中均有表达,但表达量不同.AT4G14340、AT3G23340、AT1G03930和AT3G03940基因在花中表达量最高,在根中其次,在茎、叶和叶柄中的表达量最低;A T1G04440和AT4G26100基因在根中的...     

F1代苏香杂交猪GAS7、JHDM1A基因组织表达水平研究

[目的]研究GAS7、JHDM1A基因在组织中的表达分布情况。[方法]试验采用荧光定量PCR技术,测定了苏香杂交猪的心、肝、脾、胃、肾、脑、小肠和背最长肌在各组织的分布表达情况。[结果]GAS7基因在脑表达含量最高(5.23±2.14),在心脏中表达量最低(0.07±0.03),且与脑中的表达量呈极显著差异(P<0.01),JHDM1A基因在脑部表达含量最高(32.79±12.76),在心脏(0.18±0.08)和肝脏(0.18±0.09)中表达量最低,且与脑中的表达量呈极显著差异(P<0.01)。[结论]GAS7基因主要在脑、肝脏组织表达并发挥其生理作用,而JHDM1A基因主要在脑组织表达并发挥其生理作用,此研究结果为进一步分析GAS7基因、JHDM1A基因在肉质或生长性能方面具体的分子作用机理奠定基础。     

Quantification of prion gene expression in brain and peripheral organs of golden hamster by real-time RT-PCR

Determination of tissue-specific expression of cellular prion protein (PrPc) is essential for understanding its poorly explained role in organisms. Herein we report on quantification of PrP mRNA in golden hamsters, a popular experimental model for studying mechanisms of transmissible spongiform encephalopathies (TSE), by real-time RT-PCR. Total RNA was isolated from four different regions of the brain and six peripheral organs of eight golden hamsters. PrP mRNA copy numbers were determined using absolute standard curve method with real-time quantitative PCR instrument. It was found that high mRNA levels were present in all four regions of the brain examined, including obex, neocortex, cerebellum, and thalamus. In peripheral organs examined, inguinal lymph node showed high level of the expression similar to that in overall brain; spleen, heart, liver, and lung showed moderate levels of the expression; and kidney showed the lowest expression. Our result is consistent with the potential involvement of different organs in prion diseases and offers essential data for further study of TSE mechanism in this animal model.     

Developmental regulation of rat brain/Hep G2 glucose transporter gene expression

The developmental regulation of rat brain-derived/Hep G2 glucose transporter gene expression was studied by means of Northern blot hybridization, using a rat brain glucose transporter cDNA probe, in order to directly quantify steady state glucose transporter mRNA levels. The results obtained showed different tissue-specific patterns of glucose transporter mRNA levels during ontogenesis; while in brain there was a sustained increase in the levels of the message from 20 days embryogenesis until 50 days postnatal, other organs such as heart, lung, liver, and muscle expressed maximal levels of the glucose transporter mRNA in 20-day fetuses and 1-day neonates, decreasing subsequently to very low levels. The relative expression of the glucose transporter mRNA in the different tissues, at both fetal and adult stages, was analyzed using a solution hybridization-RNase protection assay. This approach revealed that, while the heart expresses the highest levels of glucose transporter mRNA at 20 days of fetal life, the brain shows the highest levels at the adult stage. These results indicate a tissue-specific ontogenic pattern of glucose transporter gene expression, suggesting a developmental role for this glucose transporter gene product.     

Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions

Recent studies have shown that cerebral apoD levels increase with age and in Alzheimer’s disease (AD). In addition, loss of cerebral apoD in the mouse increases sensitivity to lipid peroxidation and accelerates AD pathology. Very little data are available, however, regarding the expression of apoD protein levels in different brain regions. This is important as both brain lipid peroxidation and neurodegeneration occur in a region-specific manner. Here we addressed this using western blotting of seven different regions (olfactory bulb, hippocampus, frontal cortex, striatum, cerebellum, thalamus and brain stem) of the mouse brain. Our data indicate that compared to most brain regions, the hippocampus is deficient in apoD. In comparison to other major organs and tissues (liver, spleen, kidney, adrenal gland, heart and skeletal muscle), brain apoD was approximately 10-fold higher (corrected for total protein levels). Our analysis also revealed that brain apoD was present at a lower apparent molecular weight than tissue and plasma apoD. Utilising peptide N-glycosidase-F and neuraminidase to remove N-glycans and sialic acids, respectively, we found that N-glycan composition (but not sialylation alone) were responsible for this reduction in molecular weight. We extended the studies to an analysis of human brain regions (hippocampus, frontal cortex, temporal cortex and cerebellum) where we found that the hippocampus had the lowest levels of apoD. We also confirmed that human brain apoD was present at a lower molecular weight than in plasma. In conclusion, we demonstrate apoD protein levels are variable across different brain regions, that apoD levels are much higher in the brain compared to other tissues and organs, and that cerebral apoD has a lower molecular weight than peripheral apoD; a phenomenon that is due to the N-glycan content of the protein.     

Growth hormone (GH) treatment acts on the endocrine and autocrine/paracrine GH/IGF-axis and on TNF-α expression in bony fish pituitary and immune organs

There exist indications that the growth hormone (GH)/insulin-like growth factor (IGF) axis may play a role in fish immune regulation, and that interactions occur via tumour necrosis factor (TNF)-α at least in mammals, but no systematic data exist on potential changes in GH, IGF-I, IGF-II, GH receptor (GHR) and TNF-α expression after GH treatment. Thus, we investigated in the Nile tilapia the influence of GH injections by real-time qPCR at different levels of the GH/IGF-axis (brain, pituitary, peripheral organs) with special emphasis on the immune organs head kidney and spleen. Endocrine IGF-I served as positive control for GH treatment efficiency. Basal TNF-α gene expression was detected in all organs investigated with the expression being most pronounced in brain. Two consecutive intraperitoneal injections of bream GH elevated liver IGF-I mRNA and plasma IGF-I concentration. Also liver IGF-II mRNA and TNF-α were increased while the GHR was downregulated. In brain, no change occurred in the expression levels of all genes investigated. GH gene expression was exclusively detected in the pituitary where the GH injections elevated both GH and IGF-I gene expression. In the head kidney, GH upregulated IGF-I mRNA to an even higher extent than liver IGF-I while IGF-II and GHR gene expressions were not affected. Also in the spleen, no change occurred in GHR mRNA, however, IGF-I and IGF-II mRNAs were increased. In correlation, in situ hybridisation showed a markedly higher amount of IGF-I mRNA in head kidney and spleen after GH injection. In both immune tissues, TNF-α gene expression showed a trend to decrease after GH treatment. The stimulation of IGF-I and also partially of IGF-II expression in the fish immune organs by GH indicates a local role of the IGFs in immune organ regulation while the differential changes in TNF-α support the in mammals postulated interactions with the GH/IGF-axis which demand for further investigations.     

Different coexpressions of arthritis-relevant genes between different body organs and different brain regions in the normal mouse population

Structural changes in different parts of the brain in rheumatoid arthritis (RA) patients have been reported. RA is not regarded as a brain disease. Body organs such as spleen and lung produce RA-relevant genes. We hypothesized that the structural changes in the brain are caused by changes of gene expression in body organs. Changes in different parts of the brain may be affected by altered gene expressions in different body organs. This study explored whether an association between gene expressions of an organ or a body part varies in different brain structures. By examining the association of the 10 most altered genes from a mouse model of spontaneous arthritis in a normal mouse population, we found two groups of gene expression patterns between five brain structures and spleen. The correlation patterns between the prefrontal cortex, nucleus accumbens, and spleen were similar, while the associations between the other three parts of the brain and spleen showed a different pattern. Among overall patterns of the associations between body organs and brain structures, spleen and lung had a similar pattern, and patterns for kidney and liver were similar. Analysis of the five additional known arthritis-relevant genes produced similar results. Analysis of 10 nonrelevant-arthritis genes did not result in a strong association of gene expression or clearly segregated patterns. Our data suggest that abnormal gene expressions in different diseased body organs may influence structural changes in different brain parts.     

Grb10基因在小鼠胚期特异性表达分析

生长因子受体结合蛋白10(Growth factor receptor-bound protein 10, Grb10)是一个存在于小鼠11号染色体和人7号染色体的母本表达的印记基因。文章利用原位杂交技术和定量RT-PCR方法对不同发育阶段的小鼠胚胎Grb10 基因进行时空表达谱的分析, 以确定该基因在胚胎发育中其表达与组织发育的关系。定量RT-PCR数据结果表明, Grb10在E8.5-E13.5 (Embryonic days 8.5-13.5), 表达水平逐渐增高, 在E13.5达到高峰, 后期表达量回落。在胚胎发育的中后期脑、心、肺组织的表达水平呈递减趋势。肝脏组织中Grb10表达水平较为恒定, 在E18.5出现高峰。原位杂交数据验证了定量RT-PCR的结果, 并且说明了Grb10在其他如骨、肾和肌肉等组织器官的高表达水平。研究结果表明Grb10基因是小鼠胚期发育的一个重要的基因。